| Year |
Citation |
Score |
| 2022 |
D'Oliveira da Silva F, Azevedo Neto J, Sturaro C, Guarino A, Robert C, Gavioli EC, Calo G, Mouledous L, Ruzza C. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus. Neuropharmacology. 109077. PMID 35513173 DOI: 10.1016/j.neuropharm.2022.109077 |
0.3 |
|
| 2021 |
Fritzwanker S, Moulédous L, Mollereau C, Froment C, Burlet-Schiltz O, Effah F, Bailey A, Spetea M, Reinscheid RK, Schulz S, Kliewer A. HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants. Communications Biology. 4: 1070. PMID 34522000 DOI: 10.1038/s42003-021-02580-6 |
0.711 |
|
| 2020 |
Talmont F, Veneziano R, Dietrich G, Moulédous L, Mollereau C, Zajac JM. Pharmacological insight into the activation of the human neuropeptide FF2 receptor. Peptides. 134: 170406. PMID 32920044 DOI: 10.1016/J.Peptides.2020.170406 |
0.721 |
|
| 2019 |
Coutens B, Derreumaux C, Labaste F, Minville V, Guiard BP, Moulédous L, Bounes V, Roussin A, Frances B. Efficacy of multimodal analgesic treatment of severe traumatic acute pain in mice pretreated with chronic high dose of buprenorphine inducing mechanical allodynia. European Journal of Pharmacology. 172884. PMID 31870829 DOI: 10.1016/J.Ejphar.2019.172884 |
0.673 |
|
| 2019 |
Minville V, Mouledous L, Jaafar A, Couture R, Brouchet A, Frances B, Tack I, Girolami JP. Tibial post fracture pain is reduced in kinin receptors deficient mice and blunted by kinin receptor antagonists. Journal of Translational Medicine. 17: 346. PMID 31640792 DOI: 10.1186/S12967-019-2095-9 |
0.628 |
|
| 2019 |
Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Science Signaling. 12. PMID 30914485 DOI: 10.1126/Scisignal.Aau8072 |
0.429 |
|
| 2019 |
Moulédous L. The Nociceptin/Orphanin FQ System and the Regulation of Memory. Handbook of Experimental Pharmacology. 254: 259-278. PMID 30430261 DOI: 10.1007/164_2018_185 |
0.402 |
|
| 2017 |
Rekik K, Faria Da Silva R, Colom M, Pacifico S, Zaveri NT, Calo' G, Rampon C, Frances B, Mouledous L. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation. Neuropharmacology. PMID 28705439 DOI: 10.1016/J.Neuropharm.2017.07.006 |
0.656 |
|
| 2015 |
Moulédous L, Froment C, Burlet-Schiltz O, Schulz S, Mollereau C. Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor. Febs Letters. 589: 2401-8. PMID 26226422 DOI: 10.1016/J.Febslet.2015.07.025 |
0.731 |
|
| 2015 |
Gomez-Brouchet A, Blaes N, Mouledous L, Fourcade O, Tack I, Francès B, Girolami JP, Minville V. Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice. Journal of Translational Medicine. 13: 208. PMID 26136113 DOI: 10.1186/S12967-015-0575-0 |
0.61 |
|
| 2014 |
Massaly N, Francès B, Moulédous L. Roles of the ubiquitin proteasome system in the effects of drugs of abuse. Frontiers in Molecular Neuroscience. 7: 99. PMID 25610367 DOI: 10.3389/Fnmol.2014.00099 |
0.738 |
|
| 2014 |
Bray L, Froment C, Pardo P, Candotto C, Burlet-Schiltz O, Zajac JM, Mollereau C, Moulédous L. Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor. The Journal of Biological Chemistry. 289: 33754-66. PMID 25326382 DOI: 10.1074/jbc.M114.612614 |
0.736 |
|
| 2014 |
Carayon K, Moulédous L, Combedazou A, Mazères S, Haanappel E, Salomé L, Mollereau C. Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells. The Journal of Biological Chemistry. 289: 28697-706. PMID 25183007 DOI: 10.1074/jbc.M114.588558 |
0.737 |
|
| 2014 |
Glück L, Loktev A, Moulédous L, Mollereau C, Law PY, Schulz S. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5. Biological Psychiatry. 76: 767-74. PMID 24629717 DOI: 10.1016/J.Biopsych.2014.01.021 |
0.756 |
|
| 2014 |
Talmont F, Moulédous L, Mollereau C, Zajac JM. Solubilization and reconstitution of the mu-opioid receptor expressed in human neuronal SH-SY5Y and CHO cells. Peptides. 55: 79-84. PMID 24582609 DOI: 10.1016/j.peptides.2014.02.009 |
0.746 |
|
| 2013 |
Grastilleur S, Mouledous L, Bedel J, Etcheverry J, Bader M, Girolami JP, Fourcade O, Frances B, Minville V. Role of kinin B2 receptors in opioid-induced hyperalgesia in inflammatory pain in mice. Biological Chemistry. 394: 361-8. PMID 23324378 DOI: 10.1515/Hsz-2012-0305 |
0.676 |
|
| 2013 |
Massaly N, Dahan L, Baudonnat M, Hovnanian C, Rekik K, Solinas M, David V, Pech S, Zajac JM, Roullet P, Mouledous L, Frances B. Involvement of protein degradation by the ubiquitin proteasome system in opiate addictive behaviors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 596-604. PMID 23169349 DOI: 10.1038/Npp.2012.217 |
0.755 |
|
| 2012 |
Talmont F, Moulédous L, Boué J, Mollereau C, Dietrich G. Denatured G-protein coupled receptors as immunogens to generate highly specific antibodies. Plos One. 7: e46348. PMID 23029489 DOI: 10.1371/journal.pone.0046348 |
0.707 |
|
| 2012 |
Moulédous L, Froment C, Dauvillier S, Burlet-Schiltz O, Zajac JM, Mollereau C. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors. The Journal of Biological Chemistry. 287: 12736-49. PMID 22375000 DOI: 10.1074/jbc.M111.314617 |
0.754 |
|
| 2010 |
Moulédous L, Mollereau C, Zajac JM. Opioid-modulating properties of the neuropeptide FF system. Biofactors (Oxford, England). 36: 423-9. PMID 20803521 DOI: 10.1002/biof.116 |
0.711 |
|
| 2010 |
Moulédous L, Barthas F, Zajac JM. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice. Neuropeptides. 44: 453-6. PMID 20554321 DOI: 10.1016/j.npep.2010.05.003 |
0.346 |
|
| 2010 |
Kersanté F, Moulédous L, Zajac JM, Mollereau C. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins. Neurochemistry International. 56: 768-73. PMID 20211672 DOI: 10.1016/j.neuint.2010.02.014 |
0.755 |
|
| 2010 |
Betourne A, Marty V, Ceccom J, Halley H, Lassalle JM, Zajac JM, Frances B, Mouledous L. Central locomotor and cognitive effects of a NPFF receptor agonist in mouse. Peptides. 31: 221-6. PMID 19931330 DOI: 10.1016/J.Peptides.2009.11.009 |
0.639 |
|
| 2009 |
Talmont F, Moulédous L, Piedra-Garcia L, Schmitt M, Bihel F, Bourguignon JJ, Zajac JM, Mollereau C. Pharmacological characterization of the mouse NPFF2 receptor. Peptides. 31: 215-20. PMID 19944730 DOI: 10.1016/j.peptides.2009.11.020 |
0.707 |
|
| 2008 |
Artinian J, McGauran AM, De Jaeger X, Mouledous L, Frances B, Roullet P. Protein degradation, as with protein synthesis, is required during not only long-term spatial memory consolidation but also reconsolidation. The European Journal of Neuroscience. 27: 3009-19. PMID 18588539 DOI: 10.1111/J.1460-9568.2008.06262.X |
0.623 |
|
| 2008 |
Moulédous L, Merker S, Neasta J, Roux B, Zajac J, Mollereau C. Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells Biochemical and Biophysical Research Communications. 373: 80-84. PMID 18544342 DOI: 10.1016/J.Bbrc.2008.05.174 |
0.73 |
|
| 2007 |
Moulédous L, Díaz MF, Gutstein HB. Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse. Pharmacology, Biochemistry, and Behavior. 88: 39-46. PMID 17764731 DOI: 10.1016/j.pbb.2007.07.002 |
0.651 |
|
| 2005 |
Moulédous L, Neasta J, Uttenweiler-Joseph S, Stella A, Matondo M, Corbani M, Monsarrat B, Meunier JC. Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization. Molecular Pharmacology. 68: 467-76. PMID 15901846 DOI: 10.1124/mol.105.013391 |
0.345 |
|
| 2004 |
Moulédous L, Diaz MF, Gutstein HB. Modulation of extracellular signal-regulated kinase (ERK) activity by acute and chronic opioid treatment in neuronal and glial cell lines. Journal of Neurochemistry. 90: 1371-7. PMID 15341521 DOI: 10.1111/j.1471-4159.2004.02610.x |
0.65 |
|
| 2003 |
Moulédous L, Hunt S, Harcourt R, Harry J, Williams KL, Gutstein HB. Navigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples. Proteomics. 3: 610-5. PMID 12748941 DOI: 10.1002/pmic.200300398 |
0.592 |
|
| 2003 |
Moulédous L, Gutstein HB. Gene arrays and proteomics. A primer. Methods in Molecular Medicine. 84: 141-54. PMID 12703322 DOI: 10.1385/1-59259-379-8:141 |
0.53 |
|
| 2003 |
Moulédous L, Hunt S, Harcourt R, Harry JL, Williams KL, Gutstein HB. Proteomic analysis of immunostained, laser-capture microdissected brain samples. Electrophoresis. 24: 296-302. PMID 12652601 DOI: 10.1002/elps.200390026 |
0.595 |
|
| 2003 |
Cha EY, Moulédous L, Harris JR, Weech MA, Gutstein HB. Nitroglycerin inhibits the development of morphine tolerance and dependence in rats. Pharmacology, Biochemistry, and Behavior. 74: 551-7. PMID 12543218 DOI: 10.1016/S0091-3057(02)01036-5 |
0.627 |
|
| 2002 |
Mouledous L, Hunt S, Harcourt R, Harry JL, Williams KL, Gutstein HB. Lack of compatibility of histological staining methods with proteomic analysis of laser-capture microdissected brain samples. Journal of Biomolecular Techniques : Jbt. 13: 258-64. PMID 19498991 |
0.594 |
|
| Show low-probability matches. |